Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     infertility Treatment     General & Plastic Surgery    

Global Ablation Devices Market

PRODUCT TITLE PUBLISHED
Radiofrequency Ablation Radiofrequency Ablation
The Global Radiofrequency Ablation Market was pegged at $1918 million in 2013 and expected to be $3854 million by 2018. This report also provides an extensive competitive landscaping of companies operating in radiofrequency ablation market. The key players in radiofrequency ablation market are Covidien (Ireland), Boston Scientific (U.S.), Biosense Inc. (U.S.), St. Jude Medical (U.S.), AngioDynamics (U.S.) and Medtronic Inc. (U.S.).
Upcoming
Americas Electrical Ablation Americas Electrical Ablation
The American Electrical Ablation Market was pegged at $387 million in 2013 and expected to be $480 million by 2018,. In electrical ablation market, electrical ablators accounted for a share of 90.4% in 2011. The main companies operating in electrical ablation market are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific (U.S), Angiodynamics (U.S), and Covidien (Ireland).
Upcoming
Asia-Pacific Electrical Ablation Asia-Pacific Electrical Ablation
The Asia-Pacific electrical ablation market was valued at $159.0 million in 2013 and is expected to reach $236.0 million by 2018. In the electrical ablation market, electrical ablators accounted for a share of 90.4% in 2011. The main companies operating in Asia-Pacific Electrical Ablation market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific Corporation (U.S), AngioDynamics (U.S), and Covidien plc (Ireland).
Upcoming
European Electrical Ablation European Electrical Ablation
The European electrical ablation market was valued at $189.0 million in 2013 and is expected to reach $228.0 million by 2018. In the European electrical ablation market, electrical ablators accounted for a share of 90.4% in 2011. The main companies operating in this market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific Corporation (U.S), AngioDynamics (U.S), and Covidien plc (Ireland).
Upcoming
Americas Hydrothermal Ablation Americas Hydrothermal Ablation
The American Hydrothermal Ablation Market, mainly driven by growing aging population, with increasing incidence, and prevalence of chronic diseases such as cancer and cardiovascular disorders, rapid acceptance of new medical technology, and well covered reimbursement system. The main companies operating in hydrothermal ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others
Upcoming
Asia-Pacific Hydrothermal Ablation Asia-Pacific Hydrothermal Ablation
The Asia-Pacific Hydrothermal Ablation Market, mainly driven by increasing aging population with higher risk of chronic diseases and increasing age related chronic diseases. The main companies operating in Hydrothermal Ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others.
Upcoming
European Hydrothermal Ablation European Hydrothermal Ablation
The European Hydrothermal Ablation Market, mainly driven by increasing aging population with higher risk of chronic diseases and increasing age related chronic diseases. The main companies operating in Hydrothermal Ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others.
Upcoming
Americas Light/Laser Ablation Americas Light/Laser Ablation
The American Light/Laser Ablation Market, was pegged at $347 million in 2013 and expected to be $527 million by 2018. The Excimer Laser market is the largest segment of Light/Laser Ablation Market. The key players operating in the optical correction Light/Laser ablation are Alcon, Abbott, Carl Zeiss followed by others.
Upcoming
Asia-Pacific Light/Laser Ablation Asia-Pacific Light/Laser Ablation
The Asia-Pacific Light/Laser Ablation Market was pegged at $192 million in 2013 and expected to be $330 million by 2018. The Excimer Laser market is the largest segment of Light/Laser Ablation Market. The key players operating in the optical correction Light/Laser ablation are Alcon, Abbott, Carl Zeiss followed by others.
Upcoming
European Light/Laser Ablation European Light/Laser Ablation
The European Light/Laser Ablation Market was pegged at $298 million in 2013 and expected to be $450 million by 2018. The Excimer Laser market is the largest segment of Light/Laser Ablation Market. The key players operating in the optical correction Light/Laser ablation are Alcon, Abbott, Carl Zeiss followed by others.  
Upcoming
Americas Microwave Ablation Americas Microwave Ablation
The American Microwave Ablation Market was pegged at $75 million in 2013 and expected to be $133 million by 2018. Currently there are very few players in microwave ablation market, major players being Synapse Medical, Microsilus Medical (U.K.) which recently entered into a strategic partnership with Angiodynamics (U.S).
Upcoming
Asia-Pacific Microwave Ablation Asia-Pacific Microwave Ablation
The Asia-Pacific Microwave Ablation Market was pegged at $15 million in 2013 and expected to be $31 million by 2018. Currently there are very few players in the Asia-Pacific Microwave Ablation market, major players being Synapse Medical, Microsilus Medical (U.K.) which recently entered into a strategic partnership with Angiodynamics (U.S).
Upcoming
European Microwave Ablation European Microwave Ablation
The European Microwave Ablation Market was pegged at $27 million in 2013 and expected to be $45 million by 2018. Currently there are very few players in European Microwave Ablation market, major players being Synapse Medical, Microsilus Medical (U.K.) which recently entered into a strategic partnership with Angiodynamics (U.S).
Upcoming
Americas Radiation Ablation Americas Radiation Ablation
The American Radiation Ablation Market, mainly driven by growing aging population, with increasing incidence, and prevalence of chronic diseases such as cancer and cardiovascular disorders, rapid acceptance of new medical technology, and well covered reimbursement system. The main companies operating in radiation ablation market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden).
Upcoming
Asia-Pacific Radiation Ablation Asia-Pacific Radiation Ablation
The Asia-Pacific Radiation Ablation Market was pegged at $559 million in 2013 and expected to be $899 million by 2018. It accounts for over 33% of the total ablation technologies market and expected to continue enjoying a major share in Radiation Ablation market. The main companies operating in Asia-Pacific radiation ablation market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden).
Upcoming
European Radiation Ablation European Radiation Ablation
The European Radiation Ablation Market was pegged at $864 million in 2013 and expected to be $1223 million by 2018. The main companies operating in European radiation ablation devices market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden).
Upcoming
Americas Radiofrequency Ablation Americas Radiofrequency Ablation
The Global Radiofrequency Ablation Market,  was pegged at $1160 million in 2013 and expected to be $2313 million by 2018. The key players in Radiofrequency Ablation sector are Covidien (Ireland), Boston Scientific (U.S.), Biosense Inc. (U.S.), St. Jude Medical (U.S.), AngioDynamics (U.S.) and Medtronic Inc. (U.S.).
Upcoming
Asia-Pacific Radiofrequency Ablation Asia-Pacific Radiofrequency Ablation
The Asia-Pacific Radiofrequency Ablation Market was pegged at $303 million in 2013 and expected to be $650 million by 2018. The key players in Asia-Pacific Radiofrequency ablation sector are Covidien (Ireland), Boston Scientific (U.S.), Biosense Inc. (U.S.), St. Jude Medical (U.S.), AngioDynamics (U.S.) and Medtronic Inc. (U.S.).
Upcoming
European Radiofrequency Ablation European Radiofrequency Ablation
The European Radiofrequency Ablation Market was pegged at $1160 million in 2013 and expected to be $2313 million by 2018. The key players in European radiofrequency ablation therapy sector are Covidien (Ireland), Boston Scientific (U.S.), Biosense Inc. (U.S.), St. Jude Medical (U.S.), AngioDynamics (U.S.) and Medtronic Inc. (U.S.).
Upcoming
Americas Ultrasound Ablation Americas Ultrasound Ablation
The American Ultrasound Ablation Market was pegged at $644 million in 2013 and expected to be $1155 million by 2018. The key players in ultrasound ablation segment are InSightec(U.S), Elmed Lithotripsy(Turkey), Ethicon (J&J)(U.S), Misonix Inc.(U.S), USHIFU (U.S.), and Sonora (U.S.), a subsidiary of Misonix.
Upcoming
51 reports | Show
Connect With Us
US/CAN : +1-888-502-0539